BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27134252)

  • 21. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis.
    Rubio-Rivas M; Homs NA; Cuartero D; Corbella X
    Autoimmun Rev; 2021 Jan; 20(1):102713. PubMed ID: 33197579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleroderma renal crisis and renal involvement in systemic sclerosis.
    Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
    Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.
    Shalev T; Haviv Y; Segal E; Ehrenfeld M; Pauzner R; Levy Y; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(4):380-6. PubMed ID: 16956427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
    Pestaña-Fernández M; Rubio-Rivas M; Tolosa-Vilella C; Guillén-Del-Castillo A; Colunga-Argüelles D; Argibay A; Marí-Alfonso B; Marín-Ballvé A; Pla-Salas X; Chamorro AJ; Castro-Salomó A; Madroñero-Vuelta AB; Sánchez-García ME; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Vargas-Hitos JA; Todolí-Parra JA; Trapiella-Martínez L; Lledó GM; Freire M; Fonollosa-Pla V; Simeón-Aznar CP;
    Rheumatology (Oxford); 2021 Feb; 60(2):872-880. PubMed ID: 32844220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleroderma Renal Crisis.
    Guillevin L; Mouthon L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):475-88. PubMed ID: 26210130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.
    Ghossein C; Varga J; Fenves AZ
    Curr Rheumatol Rep; 2016 Jan; 18(1):5. PubMed ID: 26711696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
    Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
    J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scleroderma renal crisis analysis of prevalence and outcome in a large italian series.
    Montagna GL; Baruffo A; Maja L; Tirri E; Matrone C; Vatti M; Valentini G
    J Clin Rheumatol; 1997 Aug; 3(4):186-93. PubMed ID: 19078185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.
    Ostojić P; Damjanov N; Pavlov-Dolijanovic S; Radunović G
    Clin Hemorheol Microcirc; 2004; 31(4):281-5. PubMed ID: 15567898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
    Ostojic P; Stojanovski N
    Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
    Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
    J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical phenotype in scleroderma patients based on autoantibodies.
    Santos CS; Morales CM; Castro CÁ; Álvarez ED
    Rheumatol Adv Pract; 2023 Apr; 7(Suppl 1):i26-i33. PubMed ID: 36968636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis.
    Kumar U; Ramteke R; Yadav R; Ramam M; Handa R; Kumar A
    J Assoc Physicians India; 2008 Jun; 56():413-7. PubMed ID: 18822619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E; Borys O; Błaszczak P; Majdan M
    Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.